Hox Therapeutics

About:

HOX Therapeutics Ltd is a spin-off from the University of Surrey Oncology Department

Website: https://www.hoxtherapeutics.com/

Top Investors: Tangram Partners Limited

Description:

HOX Therapeutics Ltd is a spin-off from the University of Surrey Oncology Department to develop new therapeutics for cancer, based on the role of HOX genes in cancer.

Total Funding Amount:

1.85M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Guildford, Surrey, United Kingdom

Founded Date:

2013-01-01

Founders:

Hardev Pandha, Richard Morgan

Number of Employees:

1-10

Last Funding Date:

2016-09-01

IPO Status:

Private

Industries: